ProfileGDS5678 / 1431942_at
TitleAnti-VEGF and Anti-Notch treatment effect on U87 glioblastoma xenograft tumors [Mouse430_2]
OrganismMus musculus


control bevacizumab dibenzazepine GSM967852 GSM967853 GSM967854 GSM967855 GSM967856 GSM967862 GSM967863 GSM967864 GSM967865 GSM967857 GSM967858 GSM967859 GSM967860 GSM967861 18% 18% 18% 17% 17% 18% 18% 18% 17% 18% 18% 18% 18% 18% sort by agent Gene Expression Profile
Graph caption help
SampleTitleValueRank
GSM967852U87-EV human glioblastoma xenograft - Control 12.4681318
GSM967853U87-EV human glioblastoma xenograft - Control 22.4346918
GSM967854U87-EV human glioblastoma xenograft - Control 32.4389218
GSM967855U87-EV human glioblastoma xenograft - Control 42.3763417
GSM967856U87-EV human glioblastoma xenograft - Control 52.3780817
GSM967862U87-EV human glioblastoma xenograft - Bevacizumab treated 12.5013718
GSM967863U87-EV human glioblastoma xenograft - Bevacizumab treated 22.4665818
GSM967864U87-EV human glioblastoma xenograft - Bevacizumab treated 32.4115318
GSM967865U87-EV human glioblastoma xenograft - Bevacizumab treated 42.3973217
GSM967857U87-EV human glioblastoma xenograft - dibenzazepine treated 12.4227818
GSM967858U87-EV human glioblastoma xenograft - dibenzazepine treated 22.4228518
GSM967859U87-EV human glioblastoma xenograft - dibenzazepine treated 32.4010818
GSM967860U87-EV human glioblastoma xenograft - dibenzazepine treated 42.4293318
GSM967861U87-EV human glioblastoma xenograft - dibenzazepine treated 52.4290618